AGEAS SA/NV

WHO'M
ai
CUSIP

DUMMY0011
SEDOL

B83F4Z0
CIK

0001593548

ageas.com
LEI:
FIGI: -
AGS

AGEAS SA/NV
GICS: 40301030 · Sector: Insurance · Sub-Sector: -
NAME
AGEAS SA/NV
ISIN
BE0974264930
TICKER
AGS
MIC
XBRU
REUTERS
AGES.BR
BLOOMBERG
AGS BB
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
In this section you will find transaction histories for short sales.
ai
NALIZER
Short sellers are obliged to report when building up positions from 0.50% and when reducing positions up to 0.50%. If there are open positions >= 0.50% in the reporting registers, these are shown in the following overview.
Five Short sale positions >= 0.50% are currently registered as reportable-relevant
Date Position Holder Position # Action
29.05.2023 Citadel Advisors Europe Limited 0,50% 16
10.11.2022 Marshall Wace LLP 0,51% 27
12.09.2022 Point72 Europe (London) LLP 1,30% 7
19.02.2020 Citadel Europe LLP 0,53% 150
19.11.2018 Boussard & Gavaudan Investment Management LLP 0,51% 178
The overview shows all positions and their last reported status. Please note that when reducing positions, falling below the 0.50% limit means that the mandatory reporting obligations no longer have to be applied. As a rule, it can be assumed that the positions have been completely reduced following a longer period of inactivity. Positions < 0.50% are therefore only of limited significance.
Date Position Holder Position # Action
29.05.2023 Citadel Advisors Europe Limited 0,50% 16
10.11.2022 Marshall Wace LLP 0,51% 27
12.09.2022 Point72 Europe (London) LLP 1,30% 7
19.02.2020 Citadel Europe LLP 0,53% 150
19.11.2018 Boussard & Gavaudan Investment Management LLP 0,51% 178
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements
The information provided in this area is compiled with care and prepared and processed in complex technical process steps. Quality assurance is an integral part of the methods and procedures used. A plausibility check is carried out to the extent that the source data allows. Before further use, especially in the course of any investment decisions, we recommend consulting at least one second independent source for validation.